Anatomical Therapeutic Chemical (ATC) Classification

[ Brite menu | Download htext | Download json | Help ]
Search

1st Level  2nd Level  3rd Level  4th Level  5th Level  6th Level 

 A ALIMENTARY TRACT AND METABOLISM
 
 B BLOOD AND BLOOD FORMING ORGANS
 
 C CARDIOVASCULAR SYSTEM
 
 D DERMATOLOGICALS
 
 G GENITO URINARY SYSTEM AND SEX HORMONES
 
 H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
 
 J ANTIINFECTIVES FOR SYSTEMIC USE
 
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
   L01 ANTINEOPLASTIC AGENTS
   L02 ENDOCRINE THERAPY
   L03 IMMUNOSTIMULANTS
   L04 IMMUNOSUPPRESSANTS
     L04A IMMUNOSUPPRESSANTS
       L04AA Selective immunosuppressants
       L04AB Tumor necrosis factor alpha (TNF-alpha) inhibitors [DG:DG01936]
         L04AB01 Etanercept
         L04AB02 Infliximab
         L04AB03 Afelimomab
         L04AB04 Adalimumab
         L04AB05 Certolizumab pegol
           D03441  Certolizumab pegol (USAN/INN) <JP/US>
         L04AB06 Golimumab
         L04AB07 Opinercept
       L04AC Interleukin inhibitors [DG:DG02019]
       L04AD Calcineurin inhibitors [DG:DG03129]
       L04AE Sphingosine-1-phosphate (S1P) receptor modulators
       L04AF Janus-associated kinase (JAK) inhibitors
       L04AG Monoclonal antibodies
       L04AH Mammalian target of rapamycin (mTOR) kinase inhibitors
       L04AJ Complement inhibitors
       L04AK Dihydroorotate dehydrogenase (DHODH) inhibitors
       L04AX Other immunosuppressants
 
 M MUSCULO-SKELETAL SYSTEM
 
 N NERVOUS SYSTEM
 
 P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
 
 R RESPIRATORY SYSTEM
 
 S SENSORY ORGANS
 
 V VARIOUS

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: April 22, 2024
According to WHO's ATC 2024

» Japanese version